Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

NIH Awards Focus on Nanopore Technology For DNA Sequencing

Published: Monday, September 09, 2013
Last Updated: Monday, September 09, 2013
Bookmark and Share
The use of nanopore technology aimed at more accurate and efficient DNA sequencing is the main focus of grants awarded by the NIH.

Nearly $17 million to eight research teams has been awarded through the National Human Genome Research Institute Advanced DNA Sequencing Technology program.  

"Nanopore technology shows great promise, but it is still a new area of science. We have much to learn about how nanopores can work effectively as a DNA sequencing technology, which is why five of the program's eight grants are exploring this approach," said Jeffery A. Schloss, Ph.D., program director for NHGRI's Advanced DNA Sequencing Technology program and director of the Division of Genome Sciences.

Nanopore-based DNA sequencing involves threading single DNA strands through tiny pores. Individual base pairs -- the chemical letters of DNA - are then read one at a time as they pass through the nanopore. The bases are identified by measuring the difference in their effect on current flowing through the pore. For perspective, a human hair is 100,000 nanometers in diameter; a strand of DNA is only 2 nanometers in diameter. Nanopores used in DNA sequencing are 1 to 2 nanometers in diameter.

This technology offers many potential advantages over current DNA sequencing methods, said Dr. Schloss. Such advantages include real-time sequencing of single DNA molecules at low cost and the ability for the same molecule to be reassessed over and over again. Current systems involve isolating DNA and chemically labeling and copying it. DNA has to be broken up, and small segments are sequenced many times. Only the first step of isolating the DNA would be necessary with nanopore technology. 

Innovation is crucial in these as well as the other (non-nanopore) studies being funded. For example, one research team eventually hopes to use light to sequence DNA on a cell phone camera chip for under $100. 

The new grants are awarded to:  

University of Illinois, Urbana-Champaign, $2.47 million over four years (pending available funds) Principal Investigator: Oleksii Aksimentiev, Ph.D.

Dr. Aksimentiev and his colleagues plan to use nanopores as sensors. The researchers are studying the effects of combining synthetic nanopores with a light-based technique to control the flow of DNA molecules through the pores. They will use a type of spectroscopy to read the chemical sequence of the DNA.  

University of New Mexico Health Sciences Center, Albuquerque, $1.35 million over three years (pending available funds) Principal Investigator: Jeremy Edwards, Ph.D.

Dr. Edwards and his colleagues plan to develop innovative molecular biology tools to improve whole-genome sequencing, which entails reading a person's entire genetic blueprint. The researchers hope that better methods of preparing the DNA molecules for sequencing will help scientists identify and link genetic variants to disease and, ultimately, lead to new treatments.  

University of Washington, Seattle, $3.83 million over four years (pending available funds) Principal Investigator: Jens Gundlach, Ph.D.

The researchers plan to continue developing the use of nanopore DNA sequencing technology involving a type of protein nanopore called MspA. Part of their research will focus on improving the control of movement of DNA through the nanopore and on developing algorithms to identify DNA bases.

Columbia University, New York City, $5.25 million over three years (pending available funds) Principal Investigators: Jingyue Ju, Ph.D., George M. Church, Ph.D., (Harvard Medical School, Boston) and James John Russo, Ph.D. (Columbia University, New York City) 

Dr. Ju and his colleagues plan to develop a miniaturized electronic system using nanopores to analyze single molecules of DNA in real time. They will construct large arrays of nanopores to create DNA sequencing chips, enabling them to determine DNA bases during a specific biochemical reaction. They hope this technique will enable them to read large sections of DNA more accurately and rapidly than is now possible. 

Eve Biomedical, Inc., Mountain View, CA., $493,000 over two years (pending available funds) Principal Investigator: Theofilos Kotseroglou, Ph.D. 

Dr. Kotseroglou's research team intends to develop a DNA sequencing system that can sequence an entire human genome for under $100. The overall system will be based on using light to sequence DNA on a cell phone camera chip. For now, his group plans to continue studying ways to accurately read long sections of DNA and develop software tools and bioinformatics.

University of Massachusetts, Amherst, $1.07 million over four years (pending available funds) Principal Investigator: Murugappan Muthukumar, Ph.D.

Dr. Muthukumar's research group plans a theoretical approach to study several major challenges underlying nanopore-based DNA sequencing, including slowing down the rate at which DNA molecules flow through the pores, the effects of specific ions, changes in the shape of the DNA molecule and other aspects of the environment.

University of North Carolina at Chapel Hill, $2.05 million over four years (pending available funds) Principal Investigator: John Michael Ramsey, Ph.D.

Dr. Ramsey and his co-workers plan to develop a low-cost method for rapidly mapping individual genomes. Such maps will help determine how large mutations in DNA structure contribute to human disease and improve diagnostic testing using genomics. 

Electronic Biosciences, Inc., San Diego, $239,000 Principal Investigator: Anna Schibel, Ph.D.

Dr. Schibel and her co-workers will develop chemical methods to slow the rate by which single-stranded DNA molecules pass through protein nanopores. Such approaches may enable the development of faster, lower-cost DNA sequencing techniques.    

The costs of DNA sequencing have greatly declined since 2003, when the genome sequencing performed under the Human Genome Project was completed at a cost of approximately $1 billion. Only a year later, in 2004, sequencing a human genome cost an estimated $10-50 million, thanks to improvements in technologies and tools. By 2009, NHGRI met its goal of producing high-quality human genome sequences at a 100-fold reduction in price, or $100,000. While achieving another 100-fold drop in price has been difficult, sequencing a person's genome today costs about $5,000 to $6,000 <http://www.genome.gov/sequencingcosts>.

The grant numbers of the awards are the following: R01 HG007406; R01 HG006876; R01 HG005115; R01 HG007415; R43 HG007386; R01 HG002776; R01 HG007407; and R43 HG006878.

Additional information about NHGRI can be found below.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Uncovering a New Principle in Chemotherapy Resistance in Breast Cancer
The NIH study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
Thursday, July 21, 2016
NIH Funds Million-Person Medicine Study
NIH announces $55million in awards to build foundations for ambitious Cohort Program that aims to engage 1 million participants in lifestyle, environments and genetics research.
Friday, July 08, 2016
Largest-Ever Study of Breast Cancer Genetics in Black Women
The study will identify genetic factors that may underlie breast cancer disparities.
Thursday, July 07, 2016
Significant Expansion Of Data Available In The Genomic Data Commons
Cancer genomic profile information from 18,000 adult cancer patients will be added to the database.
Wednesday, June 29, 2016
Predicting Effective Drug Combinations For TB
Researchers analyzed gene regulatory networks to explain the effectiveness of an experimental drug combination against drug-resistant tuberculosis bacteria.
Wednesday, June 15, 2016
Genomic Data Commons Launched
Part of the National Cancer Moonshot, the GDC will centralize and standardize accessible data.
Tuesday, June 07, 2016
Drug Might Help Treat Sepsis
A DNA enzyme called Top1 plays a key role in turning on genes that cause inflammation in mouse and human cells in response to pathogens. A drug blocking this enzyme rescued mice from lethal inflammatory responses, suggesting a potential treatment for sepsis.
Wednesday, May 18, 2016
NIH Funds New Studies on Ethical, Legal and Social Impact of Genomic Information
Four new grants from the National Institutes of Health will support research on the ethical, legal and social questions raised by advances in genomics research and the increasing availability of genomic information.
Wednesday, May 18, 2016
Researchers Identify Genetic Links to Educational Attainment
Researchers at NIH have suggested that the large genetics analyses may be able to help discover biological pathways as well.
Thursday, May 12, 2016
Submissions Open for the Cancer Moonshot Program
NCI opens online platform to submit ideas about research for Cancer Moonshot.
Tuesday, April 19, 2016
NIH Sequences Genome of a Fungus
Researchers at the Institute have sequenced genome of human, mouse and rat Pneumocystis that cause life-threatening Pneumonia in immunosuppressed hosts.
Tuesday, April 12, 2016
Decoding Ties Between Vascular Disease, Alzheimer’s
NIH consortium uses big data, team science to uncover complex interplay of factors.
Tuesday, March 15, 2016
Researchers Find Link Between Death of Tumor-Support Cells and Cancer Metastasis
Researchers at NIH have found that the lifespan of supportive cells in a tumor may control the spread of cancer.
Tuesday, February 23, 2016
Tick Genome Reveals Secrets of a Successful Bloodsucker
NIH-funded study could lead to new tick control methods.
Tuesday, February 09, 2016
Genomic Signature Shared by Five Types of Cancer
National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer.
Monday, February 08, 2016
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Discovered Through ‘Big Data’ Analysis
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer and that, when deleted in the lungs of mice, prevents the cancer from forming.
Deciphering Inactive X Chromosomes
Untangling the Barr body of inactive X chromosomes valuable for understanding chromosome structure and gene expression.
Micro Disease-Detecting Senor Created
Researchers at McMaster University have created a microscopic disease-detecting sensor that can turn on to detect trace amounts of substances.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Uncovering a New Principle in Chemotherapy Resistance in Breast Cancer
The NIH study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
Understanding Treatment Resistant Melanoma
Researchers have determined how advanced melanoma becomes resistant; a development toward developing treatments.
Investigating ‘Black Box’ of Human Genetics
Investigations into inactive X chromosomes have shown unusual DNA repeat elements are essential for maintaining 3D structure.
Liquid Biopsies: DNA Size Matters
Study finds circulating tumour DNA can be distinguished from healthy DNA through fragment size identification.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!